Abbott integrates CGM into Tandem's automated insulin pump

Abbott (NYSEABT) and Tandem Diabetes Care (Nasdaq:TNDM) announced the integration of FreeStyle Libre 2 CGM into the t:slim X2 insulin pump.

Abbott CEO Touts Libre as 'Most Successful Medtech Product in History

Raj Mattu on LinkedIn: Abbott integrates CGM into Tandem's automated insulin pump

Cherise Shockley on LinkedIn: #diabetes #ndam #wdd2023

A Guide to Insulin Pumps and New Diabetes Technology

In the News.. Tandem Mobi released, surprising outcomes for type 2 surgery, exercise and diabetes studies, T1D at the Super Bowl, and more! - Diabetes Connections

Tandem Diabetes Care's t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott's New FreeStyle Libre® 2 Plus Sensor

Cherise Shockley on LinkedIn: “When I look back over what He brought me through, I realize I made it…

Ahmed Sasi on LinkedIn: Exploring the Therapeutic Potential of Once Weekly Basal Insulin Therapy

Artificial Pancreas System for Type 1 Diabetes—Challenges and Advancements

Ahmed Sasi on LinkedIn: #esc_2023